Examining the Influence of COVID-19 on PCOS Symptoms and the Role of Homeopathy in their Alleviation

Authors

  • R Valavan BHMS, MD (Hom), MBA Head – Scientific & Medical Affairs, Schwabe India Author
  • Poorva Tiwari BHMS, MD (Hom) Scientific Officer, Schwabe India Author

Keywords:

COVID-19, metabolic, mechanism

Abstract

Polycystic ovarian syndrome (PCOS)  is a prevalent endocrine disorder  affecting reproductive-aged women  worldwide, characterized by hormonal  imbalances, irregular menstrual cycles,  ovarian cysts, and various metabolic  disturbances, hyperandrogenism,  ovulatory dysfunction, and polycystic  ovarian morphology.1 Over the past  couple of years, the world has been  grappling with the devastating effects  of the COVID-19 pandemic caused  by the novel coronavirus, SARS CoV-2. While the primary impact of  COVID-19 is respiratory, emerging  evidence suggests that the virus can  have wide-ranging effects on other  organ systems, including the endocrine  system. When we examine its effects  on the female endocrine system, it  results in menstrual irregularities,  hormonal imbalances, fertility  issues, etc. Apart from its direct  effects, even the use of COVID-19  vaccine is also reported to influence  the menstrual cycle length, flow,  duration of menstruation, symptoms,  and abnormal bleeding without an  effect on post-menopausal vaginal  bleeding.2 All these may possibly end  up in PCOS due to multiple factors,  including hormonal imbalance, stress,  and others. Researchers have also  traced its possible mechanism to be  related to the increased androgen  activity, which make the body  vulnerable to infections. 

Downloads

Download data is not yet available.

References

Rotterdam, E.A.-S.P.c.w.g. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum. Reprod. 2004, 19, 41–47.

Farah, Stephanie, et al. "Effect of COVID‐19 vaccinations on menstrual cycle and postmenopausal bleeding among health care workers: A cross‐ sectional study." International Journal of Gynecology & Obstetrics (2023).

Winck Yamamoto, M. M., Lin Winck Yamamoto, A. K., & Barbosa, B. B. (2022). Polycystic ovary syndrome and risks

for COVID-19 infection: A comprehensive review: PCOS and COVID-19 relationship. Reviews in Endocrine & Metabolic Disorders, 23(2), 251-264. https://doi.org/10.1007/s11154-

-09715-y

Subramanian, Anuradhaa, et al. "Increased COVID-19 infections

in women with polycystic ovary syndrome: a population-based study." European journal of endocrinology 184.5 (2021): 637-

Moin A.S.M., Sathyapalan T., Butler A.E., et al. Vitamin D association with macrophage derived cytokines in polycystic ovary syndrome: an enhanced risk of COVID-19 infection? Front Endocrinol. 2021:12. doi: 10.3389/fendo.2021.638621.

Dissanayake, Harsha. "COVID-19 and metabolic syndrome." Best Practice & Research Clinical Endocrinology & Metabolism (2023): 101753.

Huffman AM, Rezq S, Basnet J, Yanes Cardozo LL, Romero DG. SARS-CoV-2 viral entry proteins in hyperandrogenemic female mice: ımplications for women with PCOS and COVID-19. Int J Mol Sci. 2021;22:4472.

Bechmann, Nicole, et al. "COVID-19 Infections in Gonads: Consequences on Fertility?." Hormone and Metabolic Research (2022).

Hussain, Nabeel, et al. "A systematic review of acute telogen effluvium, a harrowing post‐COVID‐19 manifestation." Journal of medical virology 94.4 (2022): 1391-1401.

Madaan S, Jaiswal A, Kumar S, Talwar D, Halani D. Premature ovarian failure-A long COVID sequelae. Medical Science, 2021,

(112), 1286-1290

Bestle, D.; Heindl, M.R.; Limburg, H.; Van Lam van, T.; Pilgram, O.; Moulton, H.; Stein, D.A.; Hardes, K.; Eickmann, M.; Dolnik, O.; et al. TMPRSS2 and furin are both essential for proteolytic activation

of SARS-CoV-2 in human airway cells. Life Sci. Alliance 2020, 3, e202000786.

W. Boericke, New Manual of Homoeopathic Materia Medica & Repertory [with Relationship of Remedies], Second Re-Augmented & Revised Edition Based on Ninth Edition, Reprint Edition 2002, B. Jain Publishers, New Delhi.

R. Murphy, Lotus Materia Medica, Third Revised Edition, B. Jain Publishers, New Delhi.

W. H. Burt, Physiological Materia Medica, B. Jain Publishers, New Delhi.

Hashem, Nesrein M., et al. "Potential impacts of COVID-19 on reproductive health: Scientific

findings and social dimension." Saudi Journal of Biological Sciences 28.3 (2021): 1702-1712.

Published

2023-07-25

How to Cite

Examining the Influence of COVID-19 on PCOS Symptoms and the Role of Homeopathy in their Alleviation . (2023). Homoeopathy for All, 25(6), 31–36. Retrieved from https://acspublisher.com/journals/index.php/hfa/article/view/13928